FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 52 filers reported holding FINCH THERAPEUTICS GROUP INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,019 | -15.8% | 73,839 | +2.8% | 0.00% | – |
| Q4 2022 | $34,460 | -70.5% | 71,793 | +1.9% | 0.00% | – |
| Q3 2022 | $117,000 | -38.1% | 70,429 | +5.5% | 0.00% | – |
| Q2 2022 | $189,000 | -90.7% | 66,749 | -83.5% | 0.00% | – |
| Q1 2022 | $2,038,000 | -48.4% | 404,931 | +2.3% | 0.00% | – |
| Q4 2021 | $3,946,000 | -21.6% | 395,782 | +2.2% | 0.00% | – |
| Q3 2021 | $5,035,000 | -4.9% | 387,339 | +2.9% | 0.00% | – |
| Q2 2021 | $5,297,000 | +110.6% | 376,444 | +141.8% | 0.00% | – |
| Q1 2021 | $2,515,000 | – | 155,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |